SAMANTHA ROSSO: Open Payments
NPI 1336823368 · WATERFORD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 11 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $30 |
| CORDIS US CORP. | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
Products named: Wegovy, LEQVIO, LifeVest, MYNX CONTROL, VERQUVO, NEXLETOL, OPSUMIT.
Industry payments across MI — which companies pay providers there.
